The estimation of erythropoietin levels in the blood serum and cystic fluid in patients with solitary renal cysts

Archives of Medical Science

Volumn 2, Issue 2, 2006, Pages 122-124

  Jabłonowski, Zbigniew ^a   Rysz, Jacek ^a   Paradowski, Marek ^a   Miȩkoś, Eugeniusz ^a   Rózański, Waldemar ^a   Jabłoński, Sławomir ^a   Kordiak, Jacek ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Erythropoietin; Kidney; Renal cysts

Indexed keywords

CREATININE; ERYTHROPOIETIN; HEMOGLOBIN; UREA;

ADULT; ANEMIA; ARTICLE; BLOOD EXAMINATION; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; ERYTHROCYTE; HUMAN; KIDNEY CYST; KIDNEY FAILURE; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; RETICULOCYTE COUNT;

EID: 33745798800     PISSN: 17341922     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Pinkowski R, Paradowski M, Luciak M, Rysz J, Gancarz A. Stȩżenie erytropoetyny w surowicy krwi chorych z mnogimi torbielami nerek [Polish]. Diagn Lab 1995; 31: 643-5.
2. Grantham JJ. Control of renal cyst formation and enlargement. Nephrology 1991; 2: 1524.
3. Westenfelder C. Unexpected renal actions of erythropoietin. Exp Nephrol 2002; 10: 294-8.
4. Majdan M, Ksiazek A, Koziol M, Spasiewicz D. Plasma erythropoietin level and iron reserves in haemodialysis patients with and without acquired cystic kidney disease, Int Urol Nephrol 1997; 29: 113-8.
5. Tarantino G, D'Elia F, Brusasco S, Giancaspro V, del Rosso D, et al. Acquired cystic kidney disease (ACKD): experience of a dialysis center. Arch Ital Urol Androl 2000; 72: 221-4.
6. Fernandez A, Mortal L, Rodriguez JC, Vega N, Plaza C, et al. Anemia in dialysis: its relation to acquired cystic kidney disease and serum levels of erythropoietin. Am J Nephrol 1991; 11: 12-5.
7. Pavlovic-Kentera V, demons GK, Djukanovic L, Biljanovic-Paunovic L. Erythropoietin and anemia in chronic renal failure. Exp Hematol 1987; 15: 785-9.
8. Chandra M, Miller ME, Garcia JF, Mossey RT, McVicar M. Serum immunoreactive erythropoietin levels in patients with polycystic kidney disease as compared with other hemodialysis patients. Nephron 1985; 39: 26-9.
9. Abbott KC, Agodoa LY. Polycystic kidney disease at end-stage renal disease in the United States: patient characteristics and survival. Clin Nephrol 2002; 57: 208-14.
10. Gardner Jr KD, Burnside JS, Elzinga LW, Locksley RM. Inflammatory mediators in the progression of renal cystic disease. Nephrology 1991; 2: 1532.